CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 75336-75483
Annnotations
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T219","span":{"begin":0,"end":147},"obj":"Sentence"}],"text":"Proteasome inhibitors, Bortezomib, MG132, and clasto-lactacystin β-lactone are used as paradigm control to validate the screening efficacy Results:"}
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"T98077","span":{"begin":0,"end":147},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Proteasome inhibitors, Bortezomib, MG132, and clasto-lactacystin β-lactone are used as paradigm control to validate the screening efficacy Results:"}